Drugs can remain detectable in a deceased person’s body for days to months in blood and organs, and potentially years in hair and bone. The exact timeline depends on the drug, the type of tissue sampled, and the environmental conditions the body is exposed to after death. What makes postmortem drug detection uniquely complicated is that drug concentrations don’t simply freeze in place when someone dies. They shift, degrade, and in some cases increase, making forensic interpretation far more complex than a standard drug test on a living person.
Why Drug Levels Change After Death
In a living body, drugs circulate through the bloodstream and concentrate in specific organs. The liver, lungs, heart, and gastrointestinal tract all act as reservoirs, holding far higher concentrations of certain substances than what’s found in the blood. When the heart stops, those reservoirs don’t suddenly seal off. Instead, drugs begin leaking out of organ tissues into surrounding blood and fluid through passive diffusion.
This process, called postmortem redistribution, is one of the biggest challenges in forensic toxicology. Basic, fat-soluble drugs (like many antidepressants and opioids) are especially prone to it. Blood drawn from near the heart or chest cavity often contains significantly higher drug concentrations than blood from a leg vein, simply because organs like the liver and lungs are dumping their stored drugs into nearby vessels.
Other physical changes accelerate this redistribution. Rigor mortis causes the heart’s ventricles to contract slightly, pushing small amounts of blood into the neck veins. Rising pressure in the abdomen forces blood backward from the abdominal aorta into the chest. Red blood cells get trapped in clots and break down at uneven rates throughout the body, releasing whatever drugs they were carrying. As cells die and bacteria begin breaking down tissue, drug concentrations can change even further, sometimes rising and sometimes falling depending on the substance.
How Long Specific Drugs Remain Detectable
Opioids
Opioids like morphine, fentanyl, and oxycodone are generally stable in biological samples, particularly when the body is refrigerated. Fentanyl holds up well in postmortem blood, though its metabolites degrade faster than the parent drug. In skeletal remains, morphine, codeine, and oxycodone have been detected in bone tissue even when soft tissues are no longer viable for testing. However, heroin’s signature metabolite (6-acetylmorphine) breaks down quickly and is often undetectable in bone, even when other opioids are present.
Cocaine
Cocaine presents a particular challenge because it simultaneously leaks from tissues and degrades through chemical and enzymatic breakdown. Studies of cocaine-related deaths found no consistent pattern in how concentrations changed over time. In some cases levels rose after death due to tissue release; in others they fell due to degradation. The net result is unpredictable, which is why forensic experts caution against using postmortem cocaine blood levels alone to determine cause of death. Benzoylecgonine, cocaine’s primary metabolite, is more stable and is the most commonly detected cocaine-related compound in bone tissue. In vitreous humor (the gel-like fluid inside the eye), cocaine can sometimes be detected even after it has disappeared from blood entirely.
Benzodiazepines
Stability varies dramatically within this drug class. In a six-month study of postmortem samples stored at different temperatures, some benzodiazepines held steady while others vanished. Estazolam remained stable across all conditions. Ketazolam, on the other hand, completely disappeared within one to two weeks at room temperature, converting into diazepam as it broke down. Chlordiazepoxide also degraded entirely at room temperature. Freezing samples preserved concentrations reliably. In bone, diazepam and its metabolite nordiazepam were detected in all cases where the drug had been present in blood, suggesting reasonable long-term stability in hard tissue. In vitreous humor, benzodiazepines are harder to detect. Parent drugs showed up in vitreous fluid only about 10% of cases compared to 30% in blood.
Cannabis (THC)
THC and its metabolites can be quantified in postmortem blood at concentrations as low as 0.5 nanograms per milliliter. As the interval between death and sample collection increases, the ratio of central blood concentration to peripheral blood concentration tends to rise, consistent with THC leaking from organs over time. Short-term storage (one month) at either room temperature or refrigeration doesn’t significantly change THC metabolite levels in blood. But in samples analyzed two to ten months after collection, breakdown products from decomposition can interfere with testing and make accurate measurement difficult.
Alcohol
Alcohol is the most problematic substance in postmortem toxicology because bacteria naturally produce ethanol as they break down a body. This means alcohol can appear in postmortem blood even if the person hadn’t been drinking. The amount of bacterial ethanol production depends on temperature, how long the body has been decomposing, and which microbial species are present. Higher temperatures and longer intervals before testing increase the likelihood of false-positive alcohol readings. Forensic labs use several strategies to distinguish real alcohol consumption from bacterial production, including testing vitreous humor (which is more isolated from gut bacteria) and looking for specific metabolic byproducts that only form when a living person processes alcohol.
Why the Sample Location Matters
Forensic toxicologists don’t just test blood. They pull samples from multiple sites specifically because postmortem redistribution makes any single sample unreliable. Blood from the femoral vein in the thigh is preferred over heart blood because it sits farther from the drug-rich organs of the chest and abdomen. Even so, femoral blood concentrations can still shift after death.
Vitreous humor has become an increasingly important specimen. The eye is anatomically isolated, with its own barrier that slows drug penetration. This makes vitreous fluid more resistant to postmortem redistribution. For some drugs, including cocaine and PCP, the detection window in vitreous humor is actually wider than in blood. The tradeoff is that not all drugs cross into the eye effectively, so vitreous testing works well for some substances and poorly for others.
Liver tissue provides useful qualitative information (confirming a drug was present) but its high drug-storing capacity makes it unreliable for estimating what concentration was circulating in the blood at the time of death. Urine, when available, can confirm recent drug use but doesn’t indicate how much was in the system.
Hair and Bone: Detection Over Months and Years
Hair offers the longest detection window of any specimen. Drugs become incorporated into hair as it grows, creating a timeline of use that can stretch back months. In postmortem cases, hair can remain testable for extended periods, but environmental exposure matters. Sunlight degrades drug content in hair in a time-dependent way, with losses up to 37% from sun and soil exposure. Burial slows degradation compared to surface exposure, roughly following the general forensic principle that decomposition in soil proceeds about eight times slower than in open air. Temperature has minimal effect on hair drug content between negative 30°C and 40°C, but extreme heat (60°C) for two months reduced drug levels by up to 54%. Very high humidity (above 90%) caused losses of up to 60% within two weeks.
Bone is the last tissue standing. When a body has decomposed to the point where blood, organs, and other soft tissues are gone, bone and bone marrow can still yield drug evidence. Morphine, codeine, oxycodone, diazepam, and benzoylecgonine have all been successfully detected in bone. The catch is sensitivity: only about 57% of cases where a drug was confirmed in blood also showed a positive result in bone for certain drug classes, including antidepressants and antihistamines. Bone testing is a last resort, not a first choice, but it can provide answers when nothing else remains.
Why Postmortem Drug Levels Don’t Equal Living Levels
One of the most important things to understand about postmortem drug concentrations is that they cannot be reliably compared to levels measured in living people. A blood concentration that would be therapeutic in a living patient might appear two or three times higher in a postmortem sample drawn from near the chest, purely because of drug redistribution from organs. Conversely, a drug might degrade so rapidly after death that dangerously high levels at the time of death appear moderate or low by the time testing occurs.
Professional forensic toxicology standards now require labs to account for specimen type (whether it came from a living or deceased person) and to document the uncertainty in their measurements. Guidelines from organizations like the American Academy of Forensic Sciences emphasize that postmortem drug concentrations should be interpreted alongside the full picture: the autopsy findings, the circumstances of death, the specific site the sample was drawn from, and the known redistribution behavior of each drug. A number on a toxicology report from a deceased person is a starting point for interpretation, not a definitive answer about impairment or dose.